Results showed ozekibart significantly reduced the risk of disease progression or death by 52% compared with placebo. The Food and Drug Administration (FDA) has accepted for review the Biologics ...
Credit: Bayer. Two phase 3 trials supported the approval of gadoquatrane, a novel macrocyclic GBCA for imaging CNS and non-CNS pathologies. The novel macrocyclic contrast agent delivers high-quality ...
Findings showed navacaprant did not significantly improve MADRS total scores compared with placebo in either KOASTAL-2 (P =.813) or KOASTAL-3 (P =.480). Topline data were announced from two phase 3 ...
Metastatic androgen pathway modulation-naïve or -sensitive prostate cancer was previously referred to as metastatic hormone-sensitive prostate cancer.
A voluntary recall has been issued for a lot of Beekeeper’s Naturals Saline Nasal Spray following the detection of Aspergillus mold.
Three studies show benefits in adults inadequately controlled with diet and exercise, receiving metformin, using basal insulin ...
Mesothelioma deaths and diagnoses continue to rise in the United States despite regulation limiting the use of asbestos, according to a study published online June 11 in JCO Global Oncology. Kyle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results